Surgery

Episodes 1-5 of 5

• 

  RestartResume

  Experts Discuss Longevity and Durability with TAVR

  RestartResume

  Experts Discuss Longevity and Durability with TAVR

  CME/CE

  Experts Discuss Longevity and Durability with TAVR

  • 

    

    Suzanne J. Baron, MD

  • 

    

    Jonathan A. Bradlow, MD, FACC

  • 

    

    Kendra J. Grubb, MD

• 

  RestartResume

  Surgical Management of Crohn's Disease & Ulcerative Colitis

  RestartResume

  Surgical Management of Crohn's Disease & Ulcerative Colitis

  Crohn’s & Colitis Foundation Perspectives

  Surgical Management of Crohn's Disease & Ulcerative Colitis

  • 

    

    Rebecca Kaplan

  • 

    

    Michael E. Kwiatt, MD

• 

  RestartResume

  Vedolizumab as Induction and Maintenance Therapy for Crohn’s Disease in Patients Naïve to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy

  RestartResume

  Vedolizumab as Induction and Maintenance Therapy for Crohn’s Disease in Patients Naïve to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy

  AudioAbstracts

  Vedolizumab as Induction and Maintenance Therapy for Crohn’s Disease in Patients Naïve to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy

• 

  RestartResume

  Key Surgical Indications for IBD Patients

  RestartResume

  Key Surgical Indications for IBD Patients

  Crohn’s & Colitis Foundation Perspectives

  Key Surgical Indications for IBD Patients

  • 

    

    Lea Ann Chen, MD

  • 

    

    Miguel Regueiro, MD, AGAF

• 

  RestartResume

  Hospital Management of Severe Colitis: Utilization of Medical Rescue Therapies

  RestartResume

  Hospital Management of Severe Colitis: Utilization of Medical Rescue Therapies

  Crohn’s & Colitis Foundation Perspectives

  Hospital Management of Severe Colitis: Utilization of Medical Rescue Therapies

  • 

    

    Caren Heller, MD

  • 

    

    Adam S. Cheifetz, MD